The level of LC3B in GlycoA+ NRBC positively correlated with the hemoglobin (Hb) levels in high-risk MDS patients (n = 23, r = 0.5292, P = 0.0094) (Figure 5(b)). The gene discussed is MAP1LC3B; the disease is myelodysplastic syndrome.